Patents by Inventor Jozsef Karman

Jozsef Karman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF T-CELL ACTIVATION
    Publication number: 20210380686
    Abstract: The present invention provides a bispecific biologic comprising a ligand specific for CTLA-4 and a ligand specific for a pMHC complex.
    Type: Application
    Filed: May 3, 2021
    Publication date: December 9, 2021
    Inventors: Yunxiang Zhu, Jozsef Karman, Ronnie Wei, Canwen Jiang, Seng Cheng
  • Inhibitors of T-cell activation
    Patent number: 11028170
    Abstract: The present invention provides a bispecific biologic comprising a ligand specific for CTLA-4 and a ligand specific for a pMHC complex.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: June 8, 2021
    Assignee: GENZYME CORPORATION
    Inventors: Yunxiang Zhu, Jozsef Karman, Ronnie Wei, Canwen Jiang, Seng Cheng
  • INHIBITORS OF T-CELL ACTIVATION
    Publication number: 20180030134
    Abstract: The present invention provides a bispecific biologic comprising a ligand specific for CTLA-4 and a ligand specific for a pMHC complex.
    Type: Application
    Filed: October 19, 2017
    Publication date: February 1, 2018
    Inventors: Yunxiang Zhu, Jozsef Karman, Ronnie Wei, Canwen Jiang, Seng Cheng
  • Inhibitors of T-cell activation
    Patent number: 9834604
    Abstract: The present invention provides a bispecific biologic comprising a ligand specific for CTLA-4 and a ligand specific for a pMHC complex.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: December 5, 2017
    Assignee: GENZYME CORPORATION
    Inventors: Yunxiang Zhu, Jozsef Karman, Ronnie Wei, Canwen Jiang, Seng Cheng
  • INHIBITORS OF T-CELL ACTIVATION
    Publication number: 20140348832
    Abstract: The present invention provides a bispecific biologic comprising a ligand specific for CTLA-4 and a ligand specific for a pMHC complex.
    Type: Application
    Filed: June 29, 2012
    Publication date: November 27, 2014
    Applicant: GENZYME CORPORATION
    Inventors: Yunxiang Zhu, Jozsef Karman, Ronnie Wei, Canwen Jiang, Seng Cheng